<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.3390/antibiotics15030321</dc:identifier><dc:language>eng</dc:language><dc:creator>Ezquerra-Aznárez, José Manuel</dc:creator><dc:creator>Alonso-Román, Raquel</dc:creator><dc:creator>Lucía, Ainhoa</dc:creator><dc:creator>Andreu, Raquel</dc:creator><dc:creator>Franco, Santiago</dc:creator><dc:creator>Aínsa, José A.</dc:creator><dc:creator>Ramón-García, Santiago</dc:creator><dc:title>New Chemical Scaffold with Antimicrobial Activity Identified in a Screening of Industrial Photoactive Compounds</dc:title><dc:identifier>ART-2026-148979</dc:identifier><dc:description>Background/Objectives: The emergence of antimicrobial resistance threatens advances achieved by medicine in the last century. This situation has been exacerbated by the suboptimal outcome of screening campaigns to provide novel antimicrobials. Methods: An alternative strategy was employed to identify new chemical scaffolds with antimicrobial activity. A collection of photoactive compounds originally synthesized for industrial purposes was screened for antibacterial activity. Results: 4H-pyran-4-ylidenes were identified as active against Gram-positive bacteria. Compounds belonging to this family displayed dose-dependent bactericidal activity against both wild-type and methicillin-resistant Staphylococcus aureus. No cytotoxicity was observed in the HepG2 hepatic cell line at the concentrations required for antimicrobial activity against S. aureus. Resistance to 4H-pyran-4-ylidenes in S. aureus was associated with point mutations in the rny locus, which encodes for a ribonuclease that plays a key role in RNA homeostasis. Conclusions: These findings indicate that chemical libraries not originally intended for drug discovery can be an innovative source of chemical diversity for the development of novel antimicrobials.</dc:description><dc:date>2026</dc:date><dc:source>http://zaguan.unizar.es/record/170463</dc:source><dc:doi>10.3390/antibiotics15030321</dc:doi><dc:identifier>http://zaguan.unizar.es/record/170463</dc:identifier><dc:identifier>oai:zaguan.unizar.es:170463</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/DGA/E47-23R</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/UZ/UZ2023-CIE-01</dc:relation><dc:identifier.citation>Antibiotics 15, 3 (2026), 321 [17 pp.]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>https://creativecommons.org/licenses/by/4.0/deed.es</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>